Table 3.
PC14PE6 | Lung |
Pleural effusion |
|||
---|---|---|---|---|---|
Weight (g) | Metastasis |
Incidence | Volume (μL) | ||
Incidence | No. | ||||
Vector NK+ | 0.41 (0.24−0.65) | 6/6 | 113.0 (35–197) | 6/6 | 313.3 (20–900) |
SP-A NK+ | 0.21 (0.15−0.26)∗ | 5/5 | 25.6 (6–34)∗ | 1/5 | 80.0 (0–400) |
Vector NK– | 0.50 (0.26−0.89) | 7/7 | 148.6 (52–207) | 7/7 | 438.6 (20–1000) |
SP-A NK– | 0.34 (0.21−0.48) | 5/5 | 101.2 (41–181) | 4/5 | 400.0 (0–1200) |
PC14PE6 cells were i.v. injected into nude mice with or without NK cell depletion, and lung metastasis and pleural effusion were evaluated. Values are means (ranges).
Statistically significant difference compared with vector NK+ (P < 0.05).